VIRP.PA
Virbac S.A.
1W: +1.6%
1M: -1.7%
3M: +2.2%
YTD: -0.8%
1Y: +15.8%
3Y: +27.8%
5Y: +70.5%
€351.00 ($404.34)
-3.00 (-0.85%)
Weekly Expected Move ±4.0%
€321
€335
€349
€363
€377
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap€2.9B ($3.4B)
52W Range249.7-373.5
Volume1,764
Avg Volume5,298
Beta0.85
Dividend€1.45
Analyst Ratings
Company Info
CEOHabib Ramdani
Employees6,365
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date1992-07-07
Websitecorporate.virbac.com
13e rue LID - BP 27
Carros 06511
FR
Carros 06511
FR
33 4 92 08 71 00
About Virbac S.A.
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Latest News
No recent news
Recent Insider Trades
No insider trades found